Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, June 20, 2019
[ Thu, Jun 20th 2019
] - WOPRAI
[ Thu, Jun 20th 2019
] - WOPRAI
[ Thu, Jun 20th 2019
] - WOPRAI
[ Thu, Jun 20th 2019
] - WOPRAI
[ Thu, Jun 20th 2019
] - WOPRAI
[ Thu, Jun 20th 2019
] - WOPRAI
[ Thu, Jun 20th 2019
] - WOPRAI
[ Thu, Jun 20th 2019
] - WOPRAI
[ Thu, Jun 20th 2019
] - WOPRAI
Wed, June 19, 2019
[ Wed, Jun 19th 2019
] - WOPRAI
[ Wed, Jun 19th 2019
] - WOPRAI
[ Wed, Jun 19th 2019
] - WOPRAI
[ Wed, Jun 19th 2019
] - WOPRAI
[ Wed, Jun 19th 2019
] - WOPRAI
[ Wed, Jun 19th 2019
] - WOPRAI
[ Wed, Jun 19th 2019
] - WOPRAI
Tue, June 18, 2019
[ Tue, Jun 18th 2019
] - WOPRAI
[ Tue, Jun 18th 2019
] - WOPRAI
[ Tue, Jun 18th 2019
] - WOPRAI
[ Tue, Jun 18th 2019
] - WOPRAI
[ Tue, Jun 18th 2019
] - WOPRAI
[ Tue, Jun 18th 2019
] - WOPRAI
[ Tue, Jun 18th 2019
] - WOPRAI
[ Tue, Jun 18th 2019
] - WOPRAI
[ Tue, Jun 18th 2019
] - WOPRAI
Jason McCarthy Upgraded (BLUE) to Strong Buy and Held Target at $160 on, Jun 18th, 2019
Jason McCarthy of Maxim Group, Upgraded "bluebird bio, Inc." (BLUE) to Strong Buy and Held Target at $160 on, Jun 18th, 2019.
Jason has made no other calls on BLUE in the last 4 months.
There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Schmidt of "Leerink Swann" Downgraded from Buy to Hold on, Tuesday, March 5th, 2019
These are the ratings of the 2 analyists that currently disagree with Jason
- Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $163 on, Monday, June 17th, 2019
- Yaron Werber of "Cowen & Co." Initiated at Buy on, Tuesday, February 26th, 2019
